<DOC>
	<DOCNO>NCT00915317</DOCNO>
	<brief_summary>While vitamin D supplementation safe effective replete vitamin D level dialysis patient , impact anemia unknown . The majority hemodialysis patient require erythropoietin supplementation maintain serum hemoglobin 11 12 gm/dL , drug costly associate significant side effect . If repletion vitamin D significantly decrease erythropoietin requirement hemodialysis patient , would result substantial reduction patient care cost . Our aim study impact ergocalciferol supplementation hemodialysis patient 25-hydroxyvitamin D deficiency . The investigator anticipate approximately 30 % reduction erythropoietin dose requirement hemodialysis population .</brief_summary>
	<brief_title>Effect Vitamin D Supplementation Erythropoietin Dosage Hemodialysis Patients Who Have Vitamin D Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>All hemodialysis patient Kaiser Permanente Los Angeles Medical Center vitamin D deficiency [ define 25hydroxyvitamin D level le 30 ng/ml ] Nonrenal cause anemia ( myelodysplastic syndrome , multiple myeloma , pure red cell aplasia , thallassemia , sickle cell anemia ) Active cancer AIDS refuse erythropoeitin , intravenous iron vitamin D analog past erythropoeitin requirement great 6 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>